Revenue

Gift Card Revenue Recognized

Vertex Pharmaceuticals Gift Card Revenue Recognized remained flat by 0.0% to $51.70M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 21.4%, from $42.58M to $51.70M. Over 2 years (FY 2023 to FY 2025), Gift Card Revenue Recognized shows an upward trend with a 13.8% CAGR.

Analysis

StatementIncome Statement
SectionRevenue
First reportedQ1 2023
Last reportedQ4 2025Feb 13, 2026
Metric ID: tjx_gift_card_revenue_recognized

Historical Data

3 years
 FY'23FY'24FY'25
Value$159.60M$170.30M$206.80M
YoY Change—+6.7%+21.4%
Range$159.60M – $206.80M
CAGR+13.8%
Avg YoY Growth+14.1%
Median YoY Growth+14.1%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's gift card revenue recognized?
Vertex Pharmaceuticals (VRTX) reported gift card revenue recognized of $51.70M in Q4 2025.
How has Vertex Pharmaceuticals's gift card revenue recognized changed year-over-year?
Vertex Pharmaceuticals's gift card revenue recognized increased by 21.4% year-over-year, from $42.58M to $51.70M.
What is the long-term trend for Vertex Pharmaceuticals's gift card revenue recognized?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's gift card revenue recognized has grown at a 13.8% compound annual growth rate (CAGR), from $159.60M to $206.80M.